Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Andrew Peller Class A Common Stock T.ADW.A

Alternate Symbol(s):  ADWPF | T.ADW.B

Metals & Mining Copper
Andrew Peller Limited produces and markets wines and craft beverage alcohol products in Canada. The company offers wines under the Peller Estates, Trius, Thirty Bench, Wayne Gretzky, Sandhill, Red Rooster, Black Hills Estate Winery, Tinhorn Creek Vineyards, Gray Monk Estate Winery, Raven Conspiracy, and Conviction brands; Peller Family Vineyards, Copper Moon, Black Cellar, Vivo, Honest Lot, and... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSX:ADW.A)

Andrew Peller Limited Reports Financial Results for Second Quarter of Fiscal 2026

GlobeNewswire November 4, 2025

Andrew Peller Limited Announces Third Quarter Fiscal 2026 Dividend

GlobeNewswire November 4, 2025

Andrew Peller Limited Appoints Susan O'Brien to Board of Directors

GlobeNewswire November 4, 2025

Andrew Peller Ltd. Announces Timing of Q2 2026 Results & Conference Call

GlobeNewswire October 15, 2025

Andrew Peller Limited Announces the Final 2025 Annual General and Special Meeting Voting Results

GlobeNewswire September 19, 2025

Andrew Peller Limited Reports Financial Results for First Quarter of Fiscal 2026

GlobeNewswire August 6, 2025

Andrew Peller Limited Announces Second Quarter Fiscal 2026 Dividend

GlobeNewswire August 6, 2025

Andrew Peller Ltd. Announces Timing of Q1 2026 Results & Conference Call

GlobeNewswire July 18, 2025

Andrew Peller Limited Reports Financial Results for Fourth Quarter and Fiscal Year 2025

GlobeNewswire June 11, 2025
View More News ››

Opinion & Analysis (TSX:ADW.A)

No current opinion is available.
View More Opinion ››

Bullboard Posts (TSX:ADW.A)

Holiday Season

This quarter is typically the strongest. This year is a bit unique in that it is the first holiday season with emphasis on Canadian wine...
Jonathan9 - 4 days ago

Ontario wines see sales boost

https://www.ctvnews.ca/ottawa/article/ontario-wines-seeing-sales-boost-at-ottawa-lcbos-as-us-products-remain-in-storage/
Jonathan9 - 8 days ago

RE:RE:Question...

Interesting... thanks!
siwashrock - November 15, 2025

RE:Question...

What AI says: The main differences are consumer preference for European wine in Quebec versus New World wines in English Canada, the...
Jonathan9 - November 14, 2025

Question...

Why do they specify "English Canada'?
siwashrock - November 6, 2025

Q2 Conference Call Summary

Gaining market share in "English Canada" Net debt - down to $159 million Continuing to see growth in Sparkling and Good for you...
Jonathan9 - November 5, 2025
View more Bullboard ››

Diagnostear Technologies Inc

Diagnostear Technologies Inc

DiagnosTear Technologies Inc., an ophthalmic company, engages in developing and commercializing disruptive diagnostic ...
View More »